1454694-90-6Relevant articles and documents
Anticancer activity of 4-aminoquinoline-triazine based molecular hybrids
Manohar, Sunny,Pepe, Antonella,Velez Gerena, Christian E.,Zayas, Beatriz,Malhotra, Sanjay V.,Rawat, Diwan S.
, p. 7062 - 7067 (2014/02/14)
In this study the potential for anticancer activity of 4-aminoquinoline- triazine based hybrids has been investigated on 60 human cancer cell lines (NCI 60). The representative compounds show activity on a range of cell lines and apoptosis as the mode of growth inhibition. The Royal Society of Chemistry 2014.
4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of plasmodium falciparum
Manohar, Sunny,Khan, Shabana I.,Rawat, Diwan S.
, p. 625 - 630 (2013/06/27)
A systematic chemical modification in the triazine moiety covalently attached via suitable linkers to 4-amino-7-chloroquinolines yielded a series of new 7-chloro-4-aminoquinoline-triazine hybrids exhibiting high in vitro activity against W2 (chloroquine-resistant) and D6 (chloroquine-sensitive) strains of Plasmodium falciparum without any toxicity against mammalian cell lines (Vero, LLC-PK11, HepG2). Many of the compounds (6, 8, 10, 11, 13, 14, 16, 27, 29 and 33) showed excellent potency against chloroquine sensitive and resistant strains. In particular, compounds 6, 8, 14, 16 and 29 were found to be significantly more active than chloroquine against the chloroquine-resistant strains (W2 clone) of P. falciparum.